September 2017
TABLE OF CONTENTSCluster's lifeOur member's newsSave the dateCalls for projectsAround our themes

A great and busy start after the summer holidays for Lyonbiopole with a rich agenda!  A workshop on innovative methods to analyze skin parameters gathering a large number of public and private sector experts in the AURA Skin Biology Network, a travel to Scandinavia as part of inter-region “4 motors for Europe” mission and finally an info day dedicated to the upcoming H2020 calls related to health.


Innovation will be the focus during the month of October ... Let's meet on October 10th at the Hotel de Région for our annual big event: the Partnering Days that brings together all the regional health stakeholders working for the innovation of the future.

Cluster's life

 Lyonbiopole and Auvergne-Rhône-Alpes Region on a fact-finding mission to ScandinaviaFrom September 11 to 14, Lyonbiopole participated on an inter-region “4 motors for Europe” mission in Scandinavia, organised by the Auvergne-Rhône-Alpes Region and its 1st Vice-President, Mr. Etienne Blanc. So, the 4 regions of the 4 Motors Alliance, that are Catalonia, Bade Württemberg, Lombardy and Auvergne-Rhône-Alpes formed a delegation of 9 clusters and 3 companies of the life sciences sector, to discover major players within the Greater Copenhagen and the Skane region (South Sweden). During the 3 day mission, the cluster visited large research facilities such as Max VI and meet big pharmas (Novo Nordisk and Astra Zeneca), university and clinical teams specialised in personalised medicine and e-health.[...]
 The regional forces gathered during the workshop focusing on innovative methods to analyze skin parametersThe European Center for Dermocosmetology and Lyonbiopole have launched a joint initiative called AURA Skin Biology Network in order to gather all the experts in the field of Cutaneous Biology in Auvergne-Rhône-Alpes region. In this context, a thematic workshop was organized on September 12th in Lyon, focusing on innovative methods to analyze skin parameters. With a hundred attendees, academic researchers, clinicians and Health and Cosmetology companies, this event has been a great success and has generated new collaborations between experts on innovative skin models, biophysic and imaging and "omic" approaches.
 Successful Industrial GMP Manufacturing of RIBOXXIM, a Novel and Highly Potent Toll-like 3 Ligand for Immunotherapy of CancerRIBOXX PHARMACEUTICALS, a biotech company developing Toll-like-receptor (TLR) and RIG-I-like-Receptor (RLR) ligands, and ACCINOV, a pharmaceutical establishment for experimental drug products, announced the successful industrial GMP manufacturing, including packaging and quality control of RIBOXXIM®, a novel and highly potent Toll-like Receptor 3 (TLR3)-ligand. [...]
 Info Day, Horizon 2020 - 'Health, demographic change and wellbeing', LyonOrganised by the Health National Contact Point in collaboration with Lyonbiopole, Lyon’s hospital (HCL) and Claude Bernard University of Lyon, on September 19th, the info day brought together nearly 80 entrepreneurs, researchers and clinicians. Through to the presentations done by the Health and SME National Contact Points (NCPs), the participants had the opportunity to preview the next H2020 calls for the period 2018-2020. Calls will be officially published on October 27th. In order to illustrate the presentations, Prof. Douek (HCL) and Mr. Chereul (VOXCAN) presented their collaboration in a current H2020 project, demonstrating the relevance of the regional ecosystem within EU projects. In the afternoon, more than 20 bilateral meetings took place in parallel between the participants and the representatives of the Health and SME NCPs. This was an opportunity for many of our members to identify funding possibilities for their project at the European level. Save the date: the EC will organise a brokerage event and an infoday on Dec. 7 and 8 in Brussels, more information to come. [...]

Our member's news

 New membersAxolotech develops sensorial and personalized tools for the health of children, and aims at redefining the way children correct their health problems. How? With its first product, the TOTEMIGO, Axolotech provides an all-in-one tool for rehabilitation; which scenarios are designed by the users for the users. [...]
 New membersOncoFactory operates a unique technological platform exploiting an innovative patient-derived xenograft (PDX) animal model, the avian embryo. Miniature replicas of tumors from patient samples are created in a series of embryos in only a few days, for a large range of investigations. [...]
 Focus onLXREPAIR, a French company specialized in the development of disruptive technologies for DNA repair characterization, announces it has raised ¤1.1M from KREAXI, CEAInvestment, XPAND INVESTMENT Ltd of the KIS Group, Grenoble Angels, Savoie Mont-Blanc Angels, Gentiane Participation and individual investors. [...]
 August 31th, 2017EDAP Partners with Leading US HIFU provider, Vituro Health Adds Ablatherm Robotic HIFU September 11th, 2017Transgene Receives FDA IND Approval to Begin a Clinical Trial with TG4010 + Nivolumab + Chemotherapy in the First-Line Treatment of Lung Cancer  September 19th, 2017First Patient Treated in a Phase 1b/2 Trial of TG4001 in Combination with Avelumab in HPV-Positive Cancers
 September 20th, 2017Poxel Announces PXL770 Advances into a Phase 1b Multiple Ascending Dose Trial September 26th, 2017Alma Bio Therapeutics welcomes Dr. Pierre A. Morgon as member of the board of directors September 29th, 2017Opening of Voxcan’s new site of production

Save the date

 Partnering Days
October 10th, 2017
Hospital-acquired infection 2017
November 14th, 2017
Private Inv¤stments Day
Décember 1st, 2017
  • VWR seminar at Accinov
    October 3th, 2017
  • Tech Talk NNE at Accinov
    October 19th, 2017
  • Agidens and ENNOV solutions at Accinov
    October 24th, 2017
  • Immunotherapies for Infectious Diseases (I4ID2017)
    Décember 11th, 2017

  • See All events

    Calls for projects



  • IMI call 12
    Before October 24th, 2017
  • H2020 SME instrument
    Before November 8th, 2017
  • Interreg France – Suisse
    Before November 24th, 2017
  • Around our themes

    November 8th, 2017
  • Slush
    November 30th, 2017
  • Pharmabiotics 2018
    March 14th, 2018
  • Bâtiment Domilyon

    321, avenue Jean Jaurès

    69007 Lyon

    Tel. : +33 (0)4 72 76 53 30

    Fax : +33 (0)9 55 91 30 26



    This email has been sent automatically to [[EMAIL_TO]]. Click here to unsubscribe.